- Home
- BWFG vs RCKT Comparison
BWFG vs RCKT Comparison
Compare BWFG & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BWFG | RCKT |
|---|---|---|
| Founded | 2002 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 475.4M | 401.6M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | BWFG | RCKT |
|---|---|---|
| Price | $62.21 | $3.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $55.00 | $29.73 |
| AVG Volume (30 Days) | 81.7K | ★ 2.2M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 261.79 | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | ★ $2,826,000.00 | N/A |
| Revenue This Year | $17.64 | N/A |
| Revenue Next Year | $6.21 | $64.28 |
| P/E Ratio | $42.96 | ★ N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $38.20 | $2.53 |
| 52 Week High | $61.86 | $5.45 |
Technical Indicators
Market Signals| Indicator | BWFG | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 66.73 | 40.19 |
| Support Level | $45.62 | $2.95 |
| Resistance Level | N/A | $3.63 |
| Average True Range (ATR) | 1.87 | 0.21 |
| MACD | 0.09 | -0.08 |
| Stochastic Oscillator | 95.77 | 7.05 |
Price Performance
Historical ComparisonAbout BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.